Skip to main content
Equibles

Legal & General Group Plc

Position in LYEL — Lyell Immunopharma, Inc.

CIK 764068 London, X0
Back to LYEL Full portfolio

Position in LYEL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$12,883
+$4,811 QoQ
Shares Held
917
+22.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#71
of 87 holders
Holding Since
Jun 2021
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LYEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Legal & General Group Plc holds $3,299,239,490 across 292 Biotechnology names. LYEL ranks #274 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,870,015 $928,892,550
2 REGN
Regeneron Pharmaceuticals, Inc.
 759,971 $473,872,316
3 ALNY
Alnylam Pharmaceuticals, Inc.
 924,561 $278,320,596
4 RPRX
Royalty Pharma plc
 3,800,504 $213,094,258
5 INCY
Incyte Corp
 1,605,980 $182,053,892
6 ARGX
Argenx SE
 177,164 $164,367,443
7 INSM
INSMED Inc
 826,431 $88,114,072
8 RVMD
Revolution Medicines, Inc.
 381,366 $71,422,223

All Filings in LYEL

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $12,883 917
2025-03-31 $8,072 15,005
2024-12-31 $9,603 15,005
2024-09-30 $160,626 116,397
2024-06-30 $168,775 116,397
2024-03-31 $275,465 123,527
2023-12-31 $235,059 121,165
2023-09-30 $178,112 121,165
2023-06-30 $355,437 111,773
2023-03-31 $37,875 16,049
2022-12-31 $55,690 16,049
2022-09-30 $117,639 16,049
2022-06-30 $95,361 14,626
2022-03-31 $71,644 14,187
2021-12-31 $16,997 2,196
2021-09-30 $32,500 2,196
2021-06-30 $7,730 476